Algorhythm Holdings, Inc. (RIME): Nasdaq/NYSE listing notice — Algorhythm Holdings (RIME) receives Nasdaq deficiency notice for equity below $2.5M

Algorhythm Holdings, Inc.

Stockholders' equity as of Sept 30, 2025 was $100,000, far below Nasdaq's $2.5M minimum listing requirement.
Company must submit a compliance plan by January 12, 2026; if accepted, up to 180-day extension may be granted.
No immediate impact on common stock listing; delisting appeal rights available if plan is rejected.
Nasdaq Staff's notice triggered by filing of quarterly report for period ended September 30, 2025.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Algorhythm Holdings, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

November 28, 2025, Algorhythm Holdings, Inc. (the “Company”) received a letter from the Staff of the Nasdaq Stock Market, LLC indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025 (the “Form 10-Q”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum stockholders’ equity of $2,500,000 (the “Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s stockholders’ equity as of September 30, 2

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Algorhythm Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-025393

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.